Aruljothi Subramaniam

732 total citations
8 papers, 653 citations indexed

About

Aruljothi Subramaniam is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Aruljothi Subramaniam has authored 8 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Aruljothi Subramaniam's work include Phytochemistry and biological activity of medicinal plants (3 papers), Immune Cell Function and Interaction (3 papers) and Cell death mechanisms and regulation (2 papers). Aruljothi Subramaniam is often cited by papers focused on Phytochemistry and biological activity of medicinal plants (3 papers), Immune Cell Function and Interaction (3 papers) and Cell death mechanisms and regulation (2 papers). Aruljothi Subramaniam collaborates with scholars based in United States, Singapore and India. Aruljothi Subramaniam's co-authors include Alan Prem Kumar, Gautam Sethi, Muthu K. Shanmugam, Ekambaram Perumal, Kam M. Hui, Kwang Seok Ahn, Luxi Chen, Kanjoormana Aryan Manu, S. Nanjunda Swamy and Xiaoyun Dai and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and Transplantation.

In The Last Decade

Aruljothi Subramaniam

8 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aruljothi Subramaniam United States 7 367 205 111 101 97 8 653
Julie A. Arlotti United States 15 458 1.2× 89 0.4× 104 0.9× 50 0.5× 99 1.0× 19 775
Ravindra Kamath India 11 520 1.4× 125 0.6× 114 1.0× 71 0.7× 96 1.0× 11 719
Chuan‐Chou Tu Taiwan 12 329 0.9× 168 0.8× 161 1.5× 92 0.9× 108 1.1× 17 631
Hsi‐Hsien Hsu Taiwan 12 309 0.8× 177 0.9× 145 1.3× 39 0.4× 46 0.5× 31 646
Xuanxuan Dai China 23 683 1.9× 263 1.3× 239 2.2× 93 0.9× 42 0.4× 40 1.2k
Wen-Wen Huang Taiwan 16 469 1.3× 78 0.4× 109 1.0× 60 0.6× 38 0.4× 19 700
Shafquat Azim United States 12 275 0.7× 153 0.7× 126 1.1× 50 0.5× 66 0.7× 25 554
Renaud Warin United States 12 427 1.2× 123 0.6× 66 0.6× 47 0.5× 210 2.2× 18 854
Gabriela B. Iwanski United States 7 294 0.8× 86 0.4× 41 0.4× 140 1.4× 52 0.5× 8 612

Countries citing papers authored by Aruljothi Subramaniam

Since Specialization
Citations

This map shows the geographic impact of Aruljothi Subramaniam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aruljothi Subramaniam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aruljothi Subramaniam more than expected).

Fields of papers citing papers by Aruljothi Subramaniam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aruljothi Subramaniam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aruljothi Subramaniam. The network helps show where Aruljothi Subramaniam may publish in the future.

Co-authorship network of co-authors of Aruljothi Subramaniam

This figure shows the co-authorship network connecting the top 25 collaborators of Aruljothi Subramaniam. A scholar is included among the top collaborators of Aruljothi Subramaniam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aruljothi Subramaniam. Aruljothi Subramaniam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Subramaniam, Aruljothi, Ser Yue Loo, Peramaiyan Rajendran, et al.. (2013). An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins. APOPTOSIS. 18(10). 1175–1187. 37 indexed citations
2.
Manu, Kanjoormana Aryan, Muthu K. Shanmugam, Tina H. Ong, et al.. (2013). Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular Carcinoma. PLoS ONE. 8(3). e57015–e57015. 67 indexed citations
3.
Subramaniam, Aruljothi, Muthu K. Shanmugam, Tina H. Ong, et al.. (2013). Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. British Journal of Pharmacology. 170(4). 807–821. 127 indexed citations
4.
Subramaniam, Aruljothi, Muthu K. Shanmugam, Ekambaram Perumal, et al.. (2012). Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1835(1). 46–60. 247 indexed citations
5.
Kannaiyan, Radhamani, Kanjoormana Aryan Manu, Luxi Chen, et al.. (2011). Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. APOPTOSIS. 16(10). 1028–1041. 148 indexed citations
6.
Sehajpal, P. K., B Zanker, Aruljothi Subramaniam, et al.. (1991). THE MOLECULAR BASIS FOR THE SYNERGISM BETWEEN THE CD3/αβ T CELL RECEPTOR AND THE CD2 ANTIGEN-DERIVED SIGNALS IN PROMOTING T CELL PROLIFERATION. Transplantation. 51(2). 468–474. 5 indexed citations
7.
Sehajpal, P. K., et al.. (1989). Demonstration of a direct inhibitory effect of cyclosporine on normal human T-cells with two novel models of T-cell activation as probes. Cellular Immunology. 120(1). 195–204. 6 indexed citations
8.
Subramaniam, Aruljothi, et al.. (1988). Activation of human T cells with the physiological regulator of protein kinase C. Cellular Immunology. 116(2). 439–449. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026